Litcius/Paper detail

Improved prediction of immune checkpoint blockade efficacy across multiple cancer types

Diego Chowell, Seong‐Keun Yoo, Cristina Valero, Alessandro Pastore, Chirag Krishna, Mark Lee, Douglas R. Hoen, Hongyu Shi, Daniel W. Kelly, Neal Patel, Vladimir Makarov, Xiaoxiao Ma, Lynda Vuong, Erich Sabio, Kate Weiss, Fengshen Kuo, Tobias L. Lenz, Robert Samstein, Nadeem Riaz, Prasad S. Adusumilli, Vinod P. Balachandran, George Plitas, A. Ari Hakimi, Omar Abdel‐Wahab, Alexander N. Shoushtari, Michael A. Postow, Robert J. Motzer, Marc Ladanyi, Ahmet Zehir, Michael F. Berger, Mithat Gönen, Luc G.T. Morris, Nils Weinhold, Timothy A. Chan

2021Nature Biotechnology271 citationsDOIOpen Access PDF

Topics & Concepts

Immune checkpointImmunotherapyBlockadeOncologyCancer immunotherapyMedicineCancerInternal medicineComputational biologyBiologyReceptorCancer Immunotherapy and BiomarkersCancer Genomics and DiagnosticsLung Cancer Treatments and Mutations
Improved prediction of immune checkpoint blockade efficacy across multiple cancer types | Litcius